Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock ...

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

The year 2025 marked a major leap for AI in health care, with breakthroughs in drug discovery, diagnostics, genomics and ...

Regionally adaptive governance, essential in the Indian context, remains inconsistent, with significant disparities between ...

The reported valuation aligns with where Manus had been headed before Meta intervened. The company had been raising new funds ...

Overview Layer-3 blockchains are emerging as the next evolution in scaling beyond Layer-2, offering custom environments for ...

One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

The Tesla Model 3 is the first vehicle built on Tesla's third-generation platform. It aims to reduce the entry price for electric vehicles while not making any compromise on range and performance. The ...

DNA Ginkgo Bioworks Holdings, Inc.